Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron in treatment-resistant obsessive compulsive disorder
IRCT20250523065856N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in obsessive compulsive disorder (OCD), sponsored by Guilan University of Medical Sciences. Started Jun 2025; status: completed.
02
Drugs
ondansetron
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20250523065856N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250523065856N1.